As of 2025-11-08, the Relative Valuation of Applied Therapeutics Inc (APLT) is (3.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.85 USD, the upside of Applied Therapeutics Inc based on Relative Valuation is -493.4%.
The range of the Relative Valuation is (2.53) - (4.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.7x - 12.6x | 8.6x |
| Forward P/E multiples | 7.2x - 13.3x | 10.2x |
| Fair Price | (2.53) - (4.45) | (3.34) |
| Upside | -398.0% - -623.7% | -493.4% |
| Date | P/E |
| 2025-11-06 | -2.11 |
| 2025-11-05 | -2.52 |
| 2025-11-04 | -2.85 |
| 2025-11-03 | -2.94 |
| 2025-10-31 | -3.25 |
| 2025-10-30 | -3.19 |
| 2025-10-29 | -3.45 |
| 2025-10-28 | -3.67 |
| 2025-10-27 | -3.70 |
| 2025-10-24 | -3.87 |
| 2025-10-23 | -3.87 |
| 2025-10-22 | -3.93 |
| 2025-10-21 | -4.10 |
| 2025-10-20 | -4.15 |
| 2025-10-17 | -3.62 |
| 2025-10-16 | -3.53 |
| 2025-10-15 | -3.53 |
| 2025-10-14 | -3.25 |
| 2025-10-13 | -3.22 |
| 2025-10-10 | -2.66 |
| 2025-10-09 | -2.97 |
| 2025-10-08 | -3.02 |
| 2025-10-07 | -3.02 |
| 2025-10-06 | -2.88 |
| 2025-10-03 | -2.83 |
| 2025-10-02 | -2.64 |
| 2025-10-01 | -1.98 |
| 2025-09-30 | -1.71 |
| 2025-09-29 | -1.73 |
| 2025-09-26 | -3.50 |
| 2025-09-25 | -1.58 |
| 2025-09-24 | -1.32 |
| 2025-09-23 | -1.28 |
| 2025-09-22 | -1.34 |
| 2025-09-19 | -1.23 |
| 2025-09-18 | -1.26 |
| 2025-09-17 | -1.16 |
| 2025-09-16 | -1.22 |
| 2025-09-15 | -1.18 |
| 2025-09-12 | -1.19 |
| 2025-09-11 | -1.25 |
| 2025-09-10 | -1.26 |
| 2025-09-09 | -1.24 |
| 2025-09-08 | -1.24 |
| 2025-09-05 | -1.34 |
| 2025-09-04 | -1.31 |
| 2025-09-03 | -1.45 |
| 2025-09-02 | -1.47 |
| 2025-08-29 | -1.39 |
| 2025-08-28 | -1.45 |